Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice

Arduino A. MangoniDiscipline of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA, AustraliaCorrespondence[email protected]

Richard J. WoodmanCentre for Epidemiology and Biostatistics, School of Medicine, Flinders University, Adelaide, Australia

Ganessan KichenadasseFlinders Centre for Innovation in Cancer, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA, Australia

Andrew RowlandDiscipline of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA, Australia

Michael J. SorichDiscipline of Clinical Pharmacology, School of Medicine, Flinders University and Flinders Medical Centre, Bedford Park, SA, Australia

Click to increase image sizeClick to decrease image size

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice

Information for

Open access

Opportunities

Help and information

Anti-VEGF-induced hypertension and cancer outcomes: translating research into clinical practice

Financial & competing interests disclosure

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature